Hypothesis
Pain sensitivity measured by a standardized thermal threshold test reflects senescent cell burden in the dorsal root ganglia and predicts epigenetic age acceleration across multiple clocks, even after adjusting for chronological age, comorbidities, and self‑reported pain.
Mechanistic Rationale
Senescent cells secrete SASP factors such as IL‑6, TNF‑α, and NGF that sensitize nociceptors and promote neuroinflammation, lowering heat and pressure pain thresholds【https://pmc.ncbi.nlm.nih.gov/articles/PMC6710702/】. Simultaneously, SASP drives epigenetic remodeling in circulating immune cells, advancing DNAmAge, PhenoAge, and GrimAge【https://doi.org/10.1186/s13059-021-02585-8】. Thus, pain threshold serves as a functional readout of the SASP‑immune‑epigenetic axis.
Novel Insight
We propose that the relationship is mediated by microglial priming in the spinal cord: senescent‑derived SASP enters CSF, activates spinal microglia, which then release BDNF and CCL2, further increasing neuronal excitability and lowering pain thresholds【https://pmc.ncbi.nlm.nih.gov/articles/PMC10872439/】. This central amplification creates a feedback loop that synchronizes peripheral nociceptor sensitization with systemic epigenetic aging.
Testable Predictions
- Individuals with lower heat pain thresholds will show higher CSF levels of SASP cytokines (IL‑6, TNF‑α, NGF) and increased microglial activation markers (TSPO PET signal) compared with high‑threshold peers, independent of self‑reported pain scores.
- Senolytic treatment (dasatinib + quercetin) will raise pain threshold





























